Procter & Gamble (PG) officer Andre Schulten reported a proposed sale of 4,655 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $688,195.20 and an approximate sale date of October 2, 2026. Schulten also reported selling 5,402 common shares on August 20, 2026, for an aggregate market value of $776,753.58.
Procter & Gamble officer Paul Gama reported a proposed sale of 2,646 common shares, valued at $391,184.64, through Morgan Stanley Smith Barney LLC, with the approximate sale date listed as October 2, 2026. The notice also lists 3,396 common shares sold on August 20, 2026, for an aggregate market value of $488,310.84.
PROCTER & GAMBLE Co (PG) reports that Freddy P. Bharucha, CEO – Beauty, received a grant of 9,271 stock options on September 15, 2026. The options allow him to buy an equal number of common shares at an exercise price of $146.67, exercisable from September 14, 2029 and expiring September 15, 2036. Following this grant, he holds these options directly and also has direct and indirect common stock holdings, including 1,965.4595 shares held directly and additional shares held through retirement and spousal accounts. No Rule 10b5-1 trading plan is reported.
PROCTER & GAMBLE Co (PG) reported that Chief Human Resources Officer Purushothaman Balaji received a grant of 12,336 stock options on September 15, 2026. The options carry an exercise price of $146.67 per share and are scheduled to become exercisable on September 14, 2029, expiring on September 15, 2036. After this grant, Balaji holds these 12,336 options directly, along with 15,476.7953 shares of common stock directly and 5,820.1949 shares indirectly through a retirement plan trustee. No Rule 10b5-1 trading plan is reported.
PROCTER & GAMBLE Co (PG) reported that Chairman, President and CEO Shailesh Jejurikar received a grant of stock options on September 15, 2026. The award covers 22,787 options to acquire an equal number of shares of common stock at an exercise price of $146.67 per share, expiring on September 15, 2036.
After this grant, he holds 22,787 stock options directly. His reported common stock positions total 39,325.9973 shares held directly and additional indirect holdings through a retirement plan and two trusts.
PROCTER & GAMBLE Co (PG) reported that Juliana Monteiro Santos de Azevedo, CEO - Grooming, received a grant of stock options on September 15, 2026 to acquire 14,476 shares of common stock at an exercise price of $146.67 per share, expiring September 15, 2036 and exercisable beginning September 14, 2029. Following this grant, she holds 23,601.2363 shares of common stock directly, plus indirect holdings of 163.6046 shares through a Retirement Plan Trustee and 331.21 shares through an International Stock Ownership Plan & Pension Plan. No Rule 10b5-1 trading plan is reported.
PROCTER & GAMBLE Co (PG) reported that Moses Victor Javier Aguilar, the company’s Chief Research, Development & Innovation Officer, received a grant of stock options for 3,519 shares on September 15, 2026, with an exercise price of $146.67 per share, exercisable beginning September 14, 2029 and expiring September 15, 2036. Following this grant, he holds 49,511.0935 shares of common stock directly, plus 7,476.1294 shares held through a retirement plan trustee and 428.6033 shares held through an International Stock Ownership Plan (Mexico) trustee; no Rule 10b5-1 trading plan is reported.
PROCTER & GAMBLE Co (PG) reported that director Robert Jones Portman received an award of 52 Restricted Stock Units (RSUs) of common stock on September 8, 2026, as a grant or other acquisition under compensation arrangements. Following this award, he directly holds 5,246.6454 shares (including RSUs and related dividend equivalents). No Rule 10b5-1 trading plan is reported for this transaction.
PROCTER & GAMBLE Co (symbol: PG) is the issuer of record for a Form 4 filing submitted to the SEC. McEvoy Ashley reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co (PG) reported that director Ashley McEvoy received an equity award of 207 shares of Common Stock on September 8, 2026, at a stated price of $0.00 per share. The award was made under The Procter & Gamble 2025 Stock and Incentive Compensation Plan and includes dividend equivalents in the form of Restricted Stock Units. Following this grant, McEvoy directly holds 6,228.0049 shares of PG common stock.
PROCTER & GAMBLE Co (PG) reported that director Christine M. McCarthy received an award of 258 Restricted Stock Units of common stock on September 8, 2026, as a grant or award acquisition under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Following this award (including dividend-equivalent RSUs), she directly holds 17,903.7543 shares-equivalent of PG common stock. No Rule 10b5-1 trading plan is reported for this Form 4.